Publications by authors named "Micki Klearman"

Claim this Profile
C
Cardiovascular Safety of Tocilizumab Versus Etanercept in Rheumatoid Arthritis: A Randomized Controlled Trial.
Jon T Giles, Naveed Sattar, Sherine Gabriel, Paul M Ridker, Steffen Gay, Micki Klearman

Arthritis Rheumatol· January 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
Glucocorticoid Dosages and Acute-Phase Reactant Levels at Giant Cell Arteritis Flare in a Randomized Trial of Tocilizumab.
John H Stone, Katie Tuckwell, Sophie Dimonaco, Micki Klearman, Martin Aringer

Arthritis Rheumatol· August 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Health-related quality of life in patients with giant cell arteritis treated with tocilizumab in a phase 3 randomised controlled trial.
Vibeke Strand, Sophie Dimonaco, Katie Tuckwell, Micki Klearman, Neil Collinson

Arthritis Res Ther· February 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
No difference in cardiovascular risk of tocilizumab versus abatacept for rheumatoid arthritis: A multi-database cohort study.
Seoyoung C Kim, Daniel H Solomon, James R Rogers, Sara Gale, Micki Klearman

Semin Arthritis Rheum· December 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Trial of Tocilizumab in Giant-Cell Arteritis.
John H Stone, Micki Klearman, Neil Collinson

N Engl J Med· October 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Trial of Tocilizumab in Giant-Cell Arteritis.
John H Stone, Katie Tuckwell, Sophie Dimonaco, Micki Klearman, Martin Aringer

N Engl J Med· July 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Serious adverse effects associated with glucocorticoid therapy in patients with giant cell arteritis (GCA): A nested case-control analysis.
Jessica C Wilson, Khaled Sarsour, Neil Collinson, Katie Tuckwell, David Musselman, Micki Klearman

Semin Arthritis Rheum· June 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cardiovascular Safety of Tocilizumab Versus Tumor Necrosis Factor Inhibitors in Patients With Rheumatoid Arthritis: A Multi-Database Cohort Study.
Seoyoung C Kim, Daniel H Solomon, James R Rogers, Sara Gale, Micki Klearman

Arthritis Rheumatol· June 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Incidence of outcomes potentially associated with corticosteroid therapy in patients with giant cell arteritis.
Jessica C Wilson, Khaled Sarsour, Neil Collinson, Katie Tuckwell, David Musselman, Micki Klearman

Semin Arthritis Rheum· April 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Newly diagnosed vs. relapsing giant cell arteritis: Baseline data from the GiACTA trial.
Katie Tuckwell, Neil Collinson, Sophie Dimonaco, Micki Klearman, Daniel Blockmans

Semin Arthritis Rheum· April 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Comparison of lipid and lipid-associated cardiovascular risk marker changes after treatment with tocilizumab or adalimumab in patients with rheumatoid arthritis.
Cem Gabay, Iain B McInnes, Arthur Kavanaugh, Katie Tuckwell, Micki Klearman

Ann Rheum Dis· October 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Corticosteroid-related adverse events in patients with giant cell arteritis: A claims-based analysis.
Michael S Broder, Khaled Sarsour, Eunice Chang, Neil Collinson, Katie Tuckwell, Micki Klearman

Semin Arthritis Rheum· October 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Synovial phenotypes in rheumatoid arthritis correlate with response to biologic therapeutics.
Glynn Dennis, Cécile T J Holweg, Sarah K Kummerfeld, David F Choy, A Francesca Setiadi, Micki Klearman

Arthritis Res Ther· September 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Humoral immune response to vaccines in patients with rheumatoid arthritis treated with tocilizumab: results of a randomised controlled trial (VISARA).
Clifton O Bingham, Warren Rizzo, Alan Kivitz, Azra Hassanali, Ruchi Upmanyu, Micki Klearman

Ann Rheum Dis· May 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Development and implementation of a double-blind corticosteroid-tapering regimen for a clinical trial.
Neil Collinson, Katie Tuckwell, Frank Habeck, Monique Chapman, Micki Klearman

Int J Rheumatol· April 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
An evaluation of risk factors for major adverse cardiovascular events during tocilizumab therapy.
Vijay U Rao, Andrey Pavlov, Micki Klearman, David Musselman, Jon T Giles

Arthritis Rheumatol· February 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Tocilizumab monotherapy versus adalimumab monotherapy for treatment of rheumatoid arthritis (ADACTA): a randomised, double-blind, controlled phase 4 trial.
Cem Gabay, Paul Emery, Ronald van Vollenhoven, Ara Dikranian, Rieke Alten, Micki Klearman

Lancet· May 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis